BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19845506)

  • 1. Reversible bleb formation in mast cells stimulated with antigen is Ca2+/calmodulin-dependent and bleb size is regulated by ARF6.
    Yanase Y; Carvou N; Frohman MA; Cockcroft S
    Biochem J; 2009 Dec; 425(1):179-93. PubMed ID: 19845506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continual production of phosphatidic acid by phospholipase D is essential for antigen-stimulated membrane ruffling in cultured mast cells.
    O'Luanaigh N; Pardo R; Fensome A; Allen-Baume V; Jones D; Holt MR; Cockcroft S
    Mol Biol Cell; 2002 Oct; 13(10):3730-46. PubMed ID: 12388770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling mechanisms of inhibition of phospholipase D activation by CHS-111 in formyl peptide-stimulated neutrophils.
    Chang LC; Huang TH; Chang CS; Tsai YR; Lin RH; Lee PW; Hsu MF; Huang LJ; Wang JP
    Biochem Pharmacol; 2011 Jan; 81(2):269-78. PubMed ID: 20965153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phospholipase D inhibitor FIPI potently blocks EGF-induced calcium signaling in human breast cancer cells.
    Stricker HM; Rommerswinkel N; Keil S; Gnoth SA; Niggemann B; Dittmar T
    Cell Commun Signal; 2021 Apr; 19(1):43. PubMed ID: 33832505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization and regulation of phospholipase D2 by ARF6.
    Hiroyama M; Exton JH
    J Cell Biochem; 2005 May; 95(1):149-64. PubMed ID: 15759270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-mediated phospholipase D activation in rat basophilic leukemia (RBL-2H3) cells: possible involvement of calcium/calmodulin.
    Kumada T; Nakashima S; Nakamura Y; Miyata H; Nozawa Y
    Biochim Biophys Acta; 1995 Sep; 1258(2):107-14. PubMed ID: 7548173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the roles of ADP-ribosylation factors and phospholipase D in phorbol ester-induced membrane ruffling.
    Hiroyama M; Exton JH
    J Cell Physiol; 2005 Feb; 202(2):608-22. PubMed ID: 15389577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of exocytosis by cross-linking of the IgE receptor is dependent on ADP-ribosylation factor 1-regulated phospholipase D in RBL-2H3 mast cells: evidence that the mechanism of activation is via regulation of phosphatidylinositol 4,5-bisphosphate synthesis.
    Way G; O'luanaigh N; Cockcroft S
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):63-70. PubMed ID: 10657240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential role for phospholipase D in the activation of protein kinase C and degranulation in mast cells.
    Peng Z; Beaven MA
    J Immunol; 2005 May; 174(9):5201-8. PubMed ID: 15843515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis.
    Su W; Yeku O; Olepu S; Genna A; Park JS; Ren H; Du G; Gelb MH; Morris AJ; Frohman MA
    Mol Pharmacol; 2009 Mar; 75(3):437-46. PubMed ID: 19064628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel role for phospholipase D as an endogenous negative regulator of platelet sensitivity.
    Elvers M; Grenegård M; Khoshjabinzadeh H; Münzer P; Borst O; Tian H; Di Paolo G; Lang F; Gawaz M; Lindahl TL; Fälker K
    Cell Signal; 2012 Sep; 24(9):1743-52. PubMed ID: 22579635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acid.
    Sarri E; Pardo R; Fensome-Green A; Cockcroft S
    Biochem J; 2003 Jan; 369(Pt 2):319-29. PubMed ID: 12374567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-regulated exocytosis of dense-core vesicles requires the activation of ADP-ribosylation factor (ARF)6 by ARF nucleotide binding site opener at the plasma membrane.
    Vitale N; Chasserot-Golaz S; Bailly Y; Morinaga N; Frohman MA; Bader MF
    J Cell Biol; 2002 Oct; 159(1):79-89. PubMed ID: 12379803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase d promotes lipid microdomain-associated signaling events in mast cells.
    Lisboa FA; Peng Z; Combs CA; Beaven MA
    J Immunol; 2009 Oct; 183(8):5104-12. PubMed ID: 19794068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phospholipase C, protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and redox state are involved in epigallocatechin gallate-induced phospholipase D activation in human astroglioma cells.
    Kim SY; Ahn BH; Kim J; Bae YS; Kwak JY; Min G; Kwon TK; Chang JS; Lee YH; Yoon SH; Min DS
    Eur J Biochem; 2004 Sep; 271(17):3470-80. PubMed ID: 15317582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. fMLP-induced arachidonic acid release in db-cAMP-differentiated HL-60 cells is independent of phosphatidylinositol-4, 5-bisphosphate-specific phospholipase C activation and cytosolic phospholipase A(2) activation.
    Sternfeld L; Thévenod F; Schulz I
    Arch Biochem Biophys; 2000 Jun; 378(2):246-58. PubMed ID: 10860542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic.
    Brown FD; Rozelle AL; Yin HL; Balla T; Donaldson JG
    J Cell Biol; 2001 Sep; 154(5):1007-17. PubMed ID: 11535619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of phospholipase D protects mice from occlusive thrombus formation and ischemic stroke--brief report.
    Stegner D; Thielmann I; Kraft P; Frohman MA; Stoll G; Nieswandt B
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2212-7. PubMed ID: 23868933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of phospholipase D by endothelin-1, angiotensin II, and platelet-derived growth factor in vascular smooth muscle A10 cells is mediated by small G proteins of the ADP-ribosylation factor family.
    Shome K; Rizzo MA; Vasudevan C; Andresen B; Romero G
    Endocrinology; 2000 Jun; 141(6):2200-8. PubMed ID: 10830309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel lipid-soluble thiol-redox antioxidant and heavy metal chelator, N,N'-bis(2-mercaptoethyl)isophthalamide (NBMI) and phospholipase D-specific inhibitor, 5-fluoro-2-indolyl des-chlorohalopemide (FIPI) attenuate mercury-induced lipid signaling leading to protection against cytotoxicity in aortic endothelial cells.
    Secor JD; Kotha SR; Gurney TO; Patel RB; Kefauver NR; Gupta N; Morris AJ; Haley BE; Parinandi NL
    Int J Toxicol; 2011 Dec; 30(6):619-38. PubMed ID: 21994240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.